Cresco Labs Inc. Deferred Foreign Income Tax Expense (Benefit)
Cresco Labs Inc. (CRLBF) reported Deferred Foreign Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-03-06
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 40-F · filed 2026-03-06 | |
| 2024-12-31 | $0.00 40-F · filed 2026-03-06 | $1.01M 40-F · filed 2025-03-14 |
| 2023-12-31 | $6.55M 40-F · filed 2025-03-14 |